These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16273798)

  • 1. The assessment of disease activity and outcomes in psoriatic arthritis.
    Kavanaugh A; Cassell S
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S142-7. PubMed ID: 16273798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome measures in psoriatic arthritis clinical trials.
    Reddy SM; Bingham III CO
    Curr Rheumatol Rep; 2005 Aug; 7(4):299-305. PubMed ID: 16045833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical assessment in psoriatic arthritis.
    Salvarani C; Pipitone N; Catanoso MG
    Reumatismo; 2007; 59 Suppl 1():68-72. PubMed ID: 17828349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the health-related quality of life and functional status of patients with psoriatic arthritis worse than that of patients with psoriasis alone?
    Tezel N; Yilmaz Tasdelen O; Bodur H; Gul U; Kulcu Cakmak S; Oguz ID; Karabulut E
    Int J Rheum Dis; 2015 Jan; 18(1):63-9. PubMed ID: 24460852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of disease activity measures for psoriatic arthritis: what is the best approach?
    Her M; Kavanaugh A
    Expert Rev Clin Immunol; 2014 Sep; 10(9):1241-54. PubMed ID: 25088300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing disease activity in psoriasis and psoriatic arthritis: impact on management and therapy.
    Chandran V; Maharaj AB
    Expert Rev Clin Immunol; 2016; 12(5):573-82. PubMed ID: 26807494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel methods of measuring clinical outcomes from psoriasis and psoriatic arthritis clinical trials.
    Villacorta R; Hay JW; Messali A
    Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):545-58. PubMed ID: 24820676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment tools in psoriatic arthritis.
    Mease PJ
    J Rheumatol; 2008 Jul; 35(7):1426-30. PubMed ID: 18609738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials.
    Perez-Chada LM; Gottlieb AB; Cohen J; Mease P; Duffin KC; Garg A; Latella J; Armstrong AW; Ogdie A; Merola JF
    J Am Acad Dermatol; 2020 Jan; 82(1):54-61. PubMed ID: 31163240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psoriatic arthritis. Treatment outcome parameters].
    Märker-Hermann E; Behrens F
    Z Rheumatol; 2009 Feb; 68(1):16-22. PubMed ID: 19148655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of disease activity in psoriatic arthritis.
    Helliwell PS
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S44-7. PubMed ID: 26471097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional impairment measurement in psoriatic arthritis: Importance and challenges.
    Mease P; Strand V; Gladman D
    Semin Arthritis Rheum; 2018 Dec; 48(3):436-448. PubMed ID: 30029795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review.
    Smolen JS; Schoels M; Aletaha D
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S48-50. PubMed ID: 26471734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a disease activity and responder index for psoriatic arthritis--report of the Psoriatic Arthritis Module at OMERACT 11.
    Coates LC; FitzGerald O; Mease PJ; Gladman DD; Strand V; Goel N; Campbell I; Krueger G; McHugh NJ; Helliwell PS
    J Rheumatol; 2014 Apr; 41(4):782-91. PubMed ID: 24488420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Rasch analysis to compare the psychometric properties of the Short Form 36 physical function score and the Health Assessment Questionnaire disability index in patients with psoriatic arthritis and rheumatoid arthritis.
    Taylor WJ; McPherson KM
    Arthritis Rheum; 2007 Jun; 57(5):723-9. PubMed ID: 17530670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome measures in psoriatic arthritis.
    Kavanaugh A; Cassell S
    Curr Rheumatol Rep; 2005 Jun; 7(3):195-200. PubMed ID: 15918995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial.
    Kirkham B; de Vlam K; Li W; Boggs R; Mallbris L; Nab HW; Tarallo M
    Clin Exp Rheumatol; 2015; 33(1):11-9. PubMed ID: 25535650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelines.
    Kavanaugh AF; Ritchlin CT;
    J Rheumatol; 2006 Jul; 33(7):1417-21. PubMed ID: 16724373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission in psoriatic arthritis.
    Caperon A; Helliwell PS
    J Rheumatol Suppl; 2012 Jul; 89():19-21. PubMed ID: 22751584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) Survey: Benefits and Challenges of Combined Rheumatology-dermatology Clinics.
    Okhovat JP; Ogdie A; Reddy SM; Rosen CF; Scher JU; Merola JF
    J Rheumatol; 2017 May; 44(5):693-694. PubMed ID: 28461529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.